BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sager R, Kutz A, Mueller B, Schuetz P. Procalcitonin-guided diagnosis and antibiotic stewardship revisited. BMC Med 2017;15:15. [PMID: 28114931 DOI: 10.1186/s12916-017-0795-7] [Cited by in Crossref: 125] [Cited by in F6Publishing: 114] [Article Influence: 25.0] [Reference Citation Analysis]
Number Citing Articles
1 Tujula B, Kokki M, Pulkki K, Romppanen J, Sjövall S, Tuominen H, Kokki H. The usage of procalcitonin in Finland. Acta Anaesthesiol Scand 2018;62:1092-7. [DOI: 10.1111/aas.13135] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 de Carvalho FT, Rabello Filho R, Bulgarelli L, Serpa Neto A, Deliberato RO. Procalcitonin as a Diagnostic, Therapeutic, and Prognostic Tool: a Critical Review. Curr Treat Options Infect Dis 2019;11:1-11. [DOI: 10.1007/s40506-019-0178-z] [Reference Citation Analysis]
3 Cole JL. Provider perceptions on procalcitonin testing: a survey to tailor facility implementation. Infection 2017;45:925-6. [PMID: 28983859 DOI: 10.1007/s15010-017-1074-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
4 Schuetz P, Falsey A. Procalcitonin in patients with fever: one approach does not fit all. Clinical Microbiology and Infection 2018;24:1229-30. [DOI: 10.1016/j.cmi.2018.07.022] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
5 Gruzdys V, Cahoon K, Pearson L, Lehman CM. Method Verification Shows a Negative Bias between 2 Procalcitonin Methods at Medical Decision Concentrations. J Appl Lab Med 2019;4:69-77. [PMID: 31639709 DOI: 10.1373/jalm.2018.028449] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
6 Launay E, Gras-le Guen C, Caillon J, Flamant C, Navas D, Ovetchkine P. Antibio-gouvernance en néonatalogie. Archives de Pédiatrie 2017;24:S9-S13. [DOI: 10.1016/s0929-693x(18)30038-1] [Reference Citation Analysis]
7 Sartelli M, Ansaloni L, Bartoletti M, Catena F, Cardi M, Cortese F, Di Marzo F, Pea F, Plebani M, Rossolini GM, Sganga G, Viaggi B, Viale P. The role of procalcitonin in reducing antibiotics across the surgical pathway. World J Emerg Surg 2021;16:15. [PMID: 33761972 DOI: 10.1186/s13017-021-00357-0] [Reference Citation Analysis]
8 Jiang L, Shao X, Xing W, Sun Y. Biomarkers and risk factors for sepsis in stage 5 chronic kidney disease: a retrospective case–control study. Int Urol Nephrol 2019;51:691-8. [DOI: 10.1007/s11255-018-2035-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Bindra A, Chowdhary V, Dube SK, Goyal K, Mathur P. Utility of Serum Procalcitonin in Diagnosing Paroxysmal Sympathetic Hyperactivity in Patients with Traumatic Brain Injury. Indian J Crit Care Med 2021;25:580-3. [PMID: 34177179 DOI: 10.5005/jp-journals-10071-23811] [Reference Citation Analysis]
10 Rothe K, Spinner CD, Waschulzik B, Janke C, Schneider J, Schneider H, Braitsch K, Smith C, Schmid RM, Busch DH, Katchanov J. A diagnostic algorithm for detection of urinary tract infections in hospitalized patients with bacteriuria: The "Triple F" approach supported by Procalcitonin and paired blood and urine cultures. PLoS One 2020;15:e0240981. [PMID: 33091046 DOI: 10.1371/journal.pone.0240981] [Reference Citation Analysis]
11 Kataria Y, Remick D. Sepsis Biomarkers. Methods Mol Biol 2021;2321:177-89. [PMID: 34048017 DOI: 10.1007/978-1-0716-1488-4_16] [Reference Citation Analysis]
12 Firsova VG, Parshikov VV, Kukosh MV, Mukhin AS. Antibacterial and Antifungal Therapy for Patients with Acute Pancreatitis at High Risk of Pancreatogenic Sepsis (Review). Sovrem Tekhnologii Med 2020;12:126-36. [PMID: 34513046 DOI: 10.17691/stm2020.12.1.15] [Reference Citation Analysis]
13 Zheng N, Zhu D, Han Y. Procalcitonin and C-reactive protein perform better than the neutrophil/lymphocyte count ratio in evaluating hospital acquired pneumonia. BMC Pulm Med 2020;20:166. [PMID: 32527243 DOI: 10.1186/s12890-020-01207-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
14 Liu L, Luan Y, Xiao L, Wang N, Wang J, Cui Z. The predictive value of serum procalcitonin for non-invasive positive pressure ventilation in the patients with acute exacerbation of chronic obstructive pulmonary disease. Medicine (Baltimore) 2021;100:e25547. [PMID: 33879703 DOI: 10.1097/MD.0000000000025547] [Reference Citation Analysis]
15 Molinero-Fernández Á, Moreno-Guzmán M, López MÁ, Escarpa A. Magnetic Bead-Based Electrochemical Immunoassays On-Drop and On-Chip for Procalcitonin Determination: Disposable Tools for Clinical Sepsis Diagnosis. Biosensors (Basel) 2020;10:E66. [PMID: 32560303 DOI: 10.3390/bios10060066] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
16 Joyce CM, Deasy S, Abu H, Lim YY, O'Shea PM, O'Donoghue K. Reference values for C-reactive protein and procalcitonin at term pregnancy and in the early postnatal period. Ann Clin Biochem 2021;:45632211005807. [PMID: 33730872 DOI: 10.1177/00045632211005807] [Reference Citation Analysis]
17 Wang YR, Zheng QB, Wei GF, Meng LJ, Feng QL, Yuan WJ, Ou JL, Liu WL, Li Y. Elevated PCT at ICU discharge predicts poor prognosis in patients with severe traumatic brain injury: a retrospective cohort study. J Int Med Res 2020;48:300060520922456. [PMID: 32368956 DOI: 10.1177/0300060520922456] [Reference Citation Analysis]
18 Schröder S, Klein MK, Heising B, Lemmen SW. Sustainable implementation of antibiotic stewardship on a surgical intensive care unit evaluated over a 10-year period. Infection 2020;48:117-24. [PMID: 31721022 DOI: 10.1007/s15010-019-01375-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
19 Richter DC, Dietrich M, Lalev LD, Schmitt FCF, Fiedler MO, Bruckner T, Stoerzinger D, Chiriac U, Klein S, Hackert T, Brenner T, Brinkmann A, Weigand MA. Prolonged Infusion of β-Lactams Decreases Mortality in Patients with Septic Shock: A Retrospective before-and-after Study. Antibiotics (Basel) 2021;10:687. [PMID: 34201244 DOI: 10.3390/antibiotics10060687] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
20 Schuetz P, Beishuizen A, Broyles M, Ferrer R, Gavazzi G, Gluck EH, González Del Castillo J, Jensen JU, Kanizsai PL, Kwa ALH, Krueger S, Luyt CE, Oppert M, Plebani M, Shlyapnikov SA, Toccafondi G, Townsend J, Welte T, Saeed K. Procalcitonin (PCT)-guided antibiotic stewardship: an international experts consensus on optimized clinical use. Clin Chem Lab Med 2019;57:1308-18. [PMID: 30721141 DOI: 10.1515/cclm-2018-1181] [Cited by in Crossref: 74] [Cited by in F6Publishing: 60] [Article Influence: 37.0] [Reference Citation Analysis]
21 Ni T, Chen Y, Zhao B, Ma L, Yao Y, Chen E, Zhou W, Mao E. The impact of fluid resuscitation via colon on patients with severe acute pancreatitis. Sci Rep 2021;11:12488. [PMID: 34127776 DOI: 10.1038/s41598-021-92065-7] [Reference Citation Analysis]
22 Kim DW, Cho HJ, Kim GS, Song SY, Na KJ, Oh SG, Oh BS, Jeong IS. Predictive Value of Procalcitonin for Infection and Survival in Adult Cardiogenic Shock Patients Treated with Extracorporeal Membrane Oxygenation. Chonnam Med J 2018;54:48-54. [PMID: 29399566 DOI: 10.4068/cmj.2018.54.1.48] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
23 Bass GA, Dzierba AL, Taylor B, Lane-Fall M, Kaplan LJ. Tertiary peritonitis: considerations for complex team-based care. Eur J Trauma Emerg Surg 2021. [PMID: 34302503 DOI: 10.1007/s00068-021-01750-9] [Reference Citation Analysis]
24 Nascimbeni R, Amato A, Cirocchi R, Serventi A, Laghi A, Bellini M, Tellan G, Zago M, Scarpignato C, Binda GA. Management of perforated diverticulitis with generalized peritonitis. A multidisciplinary review and position paper. Tech Coloproctol 2021;25:153-65. [PMID: 33155148 DOI: 10.1007/s10151-020-02346-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
25 Schuetz P, Bolliger R, Merker M, Christ-Crain M, Stolz D, Tamm M, Luyt CE, Wolff M, Schroeder S, Nobre V, Reinhart K, Branche A, Damas P, Nijsten M, Deliberato RO, Verduri A, Beghé B, Cao B, Shehabi Y, Jensen JS, Beishuizen A, de Jong E, Briel M, Welte T, Mueller B. Procalcitonin-guided antibiotic therapy algorithms for different types of acute respiratory infections based on previous trials. Expert Rev Anti Infect Ther 2018;16:555-64. [PMID: 29969320 DOI: 10.1080/14787210.2018.1496331] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 6.3] [Reference Citation Analysis]
26 Wussler D, Kozhuharov N, Tavares Oliveira M, Bossa A, Sabti Z, Nowak A, Murray K, du Fay de Lavallaz J, Badertscher P, Twerenbold R, Shrestha S, Flores D, Nestelberger T, Walter J, Boeddinghaus J, Zimmermann T, Koechlin L, von Eckardstein A, Breidthardt T, Mueller C. Clinical Utility of Procalcitonin in the Diagnosis of Pneumonia. Clin Chem 2019;65:1532-42. [PMID: 31615771 DOI: 10.1373/clinchem.2019.306787] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 3.7] [Reference Citation Analysis]
27 Schuetz P, Wirz Y, Sager R, Christ-Crain M, Stolz D, Tamm M, Bouadma L, Luyt CE, Wolff M, Chastre J, Tubach F, Kristoffersen KB, Burkhardt O, Welte T, Schroeder S, Nobre V, Wei L, Bucher HC, Bhatnagar N, Annane D, Reinhart K, Branche A, Damas P, Nijsten M, de Lange DW, Deliberato RO, Lima SS, Maravić-Stojković V, Verduri A, Cao B, Shehabi Y, Beishuizen A, Jensen JS, Corti C, Van Oers JA, Falsey AR, de Jong E, Oliveira CF, Beghe B, Briel M, Mueller B. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections. Cochrane Database Syst Rev 2017;10:CD007498. [PMID: 29025194 DOI: 10.1002/14651858.CD007498.pub3] [Cited by in Crossref: 37] [Cited by in F6Publishing: 89] [Article Influence: 7.4] [Reference Citation Analysis]
28 Vera IM, Kessler A, Ting LM, Harawa V, Keller T, Allen D, Njie M, Moss M, Soko M, Ahmadu A, Kadwala I, Ray S, Nyirenda TS, Mandala WL, Taylor TE, Rogerson SJ, Seydel KB, Kim K. Plasma cell-free DNA predicts pediatric cerebral malaria severity. JCI Insight 2020;5:136279. [PMID: 32554925 DOI: 10.1172/jci.insight.136279] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
29 Zhou S, Tang D, Wei S, Hu Z, Wang X, Luo D. Ralstonia mannitolilytica sepsis after elective cesarean delivery: a case report. BMC Pregnancy Childbirth 2021;21:737. [PMID: 34717569 DOI: 10.1186/s12884-021-04214-5] [Reference Citation Analysis]
30 Seymann GB, Bevins N, Wu C, Fitzgerald R. Prevalence of Discordant Procalcitonin Use at an Academic Medical Center. Am J Clin Pathol 2021:aqab201. [PMID: 34894127 DOI: 10.1093/ajcp/aqab201] [Reference Citation Analysis]
31 Emberger J, Tassone D, Stevens MP, Markley JD. The Current State of Antimicrobial Stewardship: Challenges, Successes, and Future Directions. Curr Infect Dis Rep 2018;20:31. [PMID: 29959545 DOI: 10.1007/s11908-018-0637-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
32 Gianotti L, D'Agnano S, Pettiti G, Tassone F, Giraudo G, Lauro C, Lauria G, Del Bono V, Borretta G. Persistence of Elevated Procalcitonin in a Patient with Coronavirus Disease 2019 Uncovered a Diagnosis of Medullary Thyroid Carcinoma. AACE Clin Case Rep 2021;7:288-92. [PMID: 33997278 DOI: 10.1016/j.aace.2021.05.001] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
33 Pereira J, Ribeiro A, Ferreira-Coimbra J, Barroso I, Guimarães JT, Bettencourt P, Lourenço P. Is there a C-reactive protein value beyond which one should consider infection as the cause of acute heart failure? BMC Cardiovasc Disord 2018;18:40. [PMID: 29482547 DOI: 10.1186/s12872-018-0778-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
34 Palmiter RD. The Parabrachial Nucleus: CGRP Neurons Function as a General Alarm. Trends Neurosci 2018;41:280-93. [PMID: 29703377 DOI: 10.1016/j.tins.2018.03.007] [Cited by in Crossref: 122] [Cited by in F6Publishing: 113] [Article Influence: 30.5] [Reference Citation Analysis]
35 Wang W, Yang N, Wen R, Liu CF, Zhang TN. Long Noncoding RNA: Regulatory Mechanisms and Therapeutic Potential in Sepsis. Front Cell Infect Microbiol 2021;11:563126. [PMID: 34055659 DOI: 10.3389/fcimb.2021.563126] [Reference Citation Analysis]
36 Clarizia R, Capezzuoli T, Ceccarello M, Zorzi C, Stepniewska A, Roviglione G, Mautone D, Petraglia F, Ceccaroni M. Inflammation calls for more: Severe pelvic inflammatory disease with or without endometriosis. Outcomes on 311 laparoscopically treated women. J Gynecol Obstet Hum Reprod 2021;50:101811. [PMID: 32433940 DOI: 10.1016/j.jogoh.2020.101811] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
37 Cabral L, Afreixo V, Meireles R, Vaz M, Marques M, Tourais I, Chaves C, Almeida L, Paiva JA. Procalcitonin kinetics after burn injury and burn surgery in septic and non-septic patients - a retrospective observational study. BMC Anesthesiol 2018;18:122. [PMID: 30185148 DOI: 10.1186/s12871-018-0585-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
38 Leroux P, De Ruffi S, Ramont L, Gornet M, Giordano Orsini G, Losset X, Kanagaratnam L, Gennai S. Clinical Outcome Predictive Value of Procalcitonin in Patients Suspected with Infection in the Emergency Department. Emerg Med Int 2021;2021:2344212. [PMID: 34221509 DOI: 10.1155/2021/2344212] [Reference Citation Analysis]
39 Lippi G, Salvagno GL, Gelati M, Pucci M, Demonte D, Faggian D, Plebani M. Analytical Evaluation of the New Beckman Coulter Access Procalcitonin (PCT) Chemiluminescent Immunoassay. Diagnostics (Basel) 2020;10:E128. [PMID: 32111028 DOI: 10.3390/diagnostics10030128] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
40 Seshadri P, Manoli K, Schneiderhan-Marra N, Anthes U, Wierzchowiec P, Bonrad K, Di Franco C, Torsi L. Low-picomolar, label-free procalcitonin analytical detection with an electrolyte-gated organic field-effect transistor based electronic immunosensor. Biosens Bioelectron 2018;104:113-9. [PMID: 29331425 DOI: 10.1016/j.bios.2017.12.041] [Cited by in Crossref: 50] [Cited by in F6Publishing: 35] [Article Influence: 10.0] [Reference Citation Analysis]
41 Weiss FU, Laemmerhirt F, Lerch MM. Acute Pancreatitis: Genetic Risk and Clinical Implications. J Clin Med 2021;10:E190. [PMID: 33430357 DOI: 10.3390/jcm10020190] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
42 Teehan A, Burke C, Minson Q. Evaluation of a Pharmacist-Driven Procalcitonin Protocol for Lower Respiratory Tract Infections Using a Clinical Decision Support System. Hosp Pharm 2021;56:569-75. [PMID: 34720162 DOI: 10.1177/0018578720931450] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
43 Jacobsen AA, Pearson DR. The age of procalcitonin: potential pitfalls in critically ill patients with SJS/TEN. A comment on “Risk factors and diagnostic markers of bacteremia in Stevens-Johnson syndrome and toxic epidermal necrolysis: A cohort study of 176 patients”. Journal of the American Academy of Dermatology 2020;82:e247. [DOI: 10.1016/j.jaad.2020.01.086] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
44 Covino M, Gallo A, Montalto M, De Matteis G, Burzo ML, Simeoni B, Murri R, Candelli M, Ojetti V, Franceschi F. The Role of Early Procalcitonin Determination in the Emergency Departiment in Adults Hospitalized with Fever. Medicina (Kaunas) 2021;57:179. [PMID: 33669753 DOI: 10.3390/medicina57020179] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
45 Huang M, Cai S, Su J. The Pathogenesis of Sepsis and Potential Therapeutic Targets. Int J Mol Sci 2019;20:E5376. [PMID: 31671729 DOI: 10.3390/ijms20215376] [Cited by in Crossref: 44] [Cited by in F6Publishing: 46] [Article Influence: 14.7] [Reference Citation Analysis]
46 Sager R, Wirz Y, Amin D, Amin A, Hausfater P, Huber A, Haubitz S, Kutz A, Mueller B, Schuetz P. Are admission procalcitonin levels universal mortality predictors across different medical emergency patient populations? Results from the multi-national, prospective, observational TRIAGE study. Clin Chem Lab Med 2017;55:1873-80. [PMID: 28412721 DOI: 10.1515/cclm-2017-0144] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 4.2] [Reference Citation Analysis]
47 Plata-Menchaca EP, Ferrer R, Ruiz Rodríguez JC, Morais R, Póvoa P. Antibiotic treatment in patients with sepsis: a narrative review. Hosp Pract (1995) 2020;:1-11. [PMID: 32627615 DOI: 10.1080/21548331.2020.1791541] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
48 Choi H, Tashpulatova Z, Moon SY, Choi J, Kim JY, Lee SM. Evaluation of the Beckman Coulter Access Procalcitonin Assay: analytical and clinical performance. Clin Chem Lab Med 2021. [PMID: 34668362 DOI: 10.1515/cclm-2021-0900] [Reference Citation Analysis]
49 Zurfluh S, Baumgartner T, Meier MA, Ottiger M, Voegeli A, Bernasconi L, Neyer P, Mueller B, Schuetz P. The role of metabolomic markers for patients with infectious diseases: implications for risk stratification and therapeutic modulation. Expert Rev Anti Infect Ther 2018;16:133-42. [PMID: 29316826 DOI: 10.1080/14787210.2018.1426460] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
50 Branche A, Neeser O, Mueller B, Schuetz P. Procalcitonin to guide antibiotic decision making. Curr Opin Infect Dis. 2019;32:130-135. [PMID: 30648993 DOI: 10.1097/qco.0000000000000522] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
51 Yu C, Lei Q, Li W, Wang X, Liu W, Fan X, Li W. Clinical Characteristics, Associated Factors, and Predicting COVID-19 Mortality Risk: A Retrospective Study in Wuhan, China. Am J Prev Med 2020;59:168-75. [PMID: 32564974 DOI: 10.1016/j.amepre.2020.05.002] [Cited by in Crossref: 49] [Cited by in F6Publishing: 51] [Article Influence: 24.5] [Reference Citation Analysis]
52 Ye J, Hua M, Zhu F. Machine Learning Algorithms are Superior to Conventional Regression Models in Predicting Risk Stratification of COVID-19 Patients. Risk Manag Healthc Policy 2021;14:3159-66. [PMID: 34349576 DOI: 10.2147/RMHP.S318265] [Reference Citation Analysis]
53 Dong Y, Sun D, Wang Y, Du Q, Zhang Y, Han R, Teng M, Zhang T, Shi L, Zheng G, Dong Y, Wang T. Evaluation of the current guidelines for antibacterial therapy strategies in patients with cirrhosis or liver failure. BMC Infect Dis 2022;22:23. [PMID: 34983426 DOI: 10.1186/s12879-021-07018-2] [Reference Citation Analysis]
54 Nagai M, Imai Y, Wada Y, Kusakabe M, Yamanishi K. Serum Procalcitonin and Presepsin Levels in Patients with Generalized Pustular Psoriasis. Dis Markers 2018;2018:9758473. [PMID: 30647802 DOI: 10.1155/2018/9758473] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
55 Lin MF, Sun B, Liu ZY, Tang P, Zhang LJ, Wang YY. Evaluation of the clinical diagnostic value of traditional inflammatory markers and novel biomarkers in intracellular bacterial bloodstream infections. Cytokine 2020;136:155238. [PMID: 32822910 DOI: 10.1016/j.cyto.2020.155238] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
56 Molinero-fernández Á, Moreno-guzmán M, Arruza L, López MÁ, Escarpa A. Toward Early Diagnosis of Late-Onset Sepsis in Preterm Neonates: Dual Magnetoimmunosensor for Simultaneous Procalcitonin and C-Reactive Protein Determination in Diagnosed Clinical Samples. ACS Sens 2019;4:2117-23. [DOI: 10.1021/acssensors.9b00890] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 6.3] [Reference Citation Analysis]
57 Gregoriano C, Heilmann E, Molitor A, Schuetz P. Role of procalcitonin use in the management of sepsis. J Thorac Dis 2020;12:S5-S15. [PMID: 32148921 DOI: 10.21037/jtd.2019.11.63] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 6.5] [Reference Citation Analysis]
58 Mallet M, Haq M, Tripon S, Bernard M, Benosman H, Thabut D, Rudler M. Elevated procalcitonin is associated with bacterial infection during acute liver failure only when unrelated to acetaminophen intoxication. Eur J Gastroenterol Hepatol. 2017;29:811-816. [PMID: 28272093 DOI: 10.1097/meg.0000000000000862] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
59 Heilmann E, Gregoriano C, Schuetz P. Biomarkers of Infection: Are They Useful in the ICU? Semin Respir Crit Care Med 2019;40:465-75. [PMID: 31585473 DOI: 10.1055/s-0039-1696689] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.7] [Reference Citation Analysis]
60 Lei Q, Hou H, Yu C, Zhang Y, Ndzouboukou JB, Lin X, Yao Z, Fu H, Sun Z, Wang F, Fan X. Kinetics of Neutralizing Antibody Response Underscores Clinical COVID-19 Progression. J Immunol Res 2021;2021:9822706. [PMID: 34712742 DOI: 10.1155/2021/9822706] [Reference Citation Analysis]
61 Heffernan AJ, Sime FB, Lipman J, Roberts JA. Individualising Therapy to Minimize Bacterial Multidrug Resistance. Drugs 2018;78:621-41. [PMID: 29569104 DOI: 10.1007/s40265-018-0891-9] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 7.3] [Reference Citation Analysis]
62 Cvetinovic N, Isakovic AM, Lainscak M, Dungen HD, Nikolic NM, Loncar G. Procalcitonin in heart failure: hic et nunc. Biomark Med 2017;11:893-903. [PMID: 28976777 DOI: 10.2217/bmm-2017-0160] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
63 Lee CC, Kwa ALH, Apisarnthanarak A, Feng JY, Gluck EH, Ito A, Karuniawati A, Periyasamy P, Pratumvinit B, Sharma J, Solante R, Swaminathan S, Tyagi N, Vu DM, Zirpe K, Schuetz P. Procalcitonin (PCT)-guided antibiotic stewardship in Asia-Pacific countries: adaptation based on an expert consensus meeting. Clin Chem Lab Med 2020;58:1983-91. [PMID: 31926074 DOI: 10.1515/cclm-2019-1122] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]
64 Pirofski LA, Casadevall A. Antimicrobial Therapy in the Context of the Damage-Response Framework: the Prospect of Optimizing Therapy by Reducing Host Damage. Antimicrob Agents Chemother 2020;64:e01800-19. [PMID: 31740558 DOI: 10.1128/AAC.01800-19] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
65 Martínez ML, Plata-Menchaca EP, Ruiz-Rodríguez JC, Ferrer R. An approach to antibiotic treatment in patients with sepsis. J Thorac Dis 2020;12:1007-21. [PMID: 32274170 DOI: 10.21037/jtd.2020.01.47] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
66 Ye J, Zhang X, Zhu F, Tang Y. Application of a prediction model with laboratory indexes in the risk stratification of patients with COVID-19. Exp Ther Med 2021;21:182. [PMID: 33488791 DOI: 10.3892/etm.2021.9613] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
67 Dobiáš R, Káňová M, Petejová N, Pisti ŠK, Bocek R, Krejčí E, Stružková H, Cachová M, Tomášková H, Hamal P, Havlíček V, Raška M. Combined Use of Presepsin and (1,3)-β-D-glucan as Biomarkers for Diagnosing Candida Sepsis and Monitoring the Effectiveness of Treatment in Critically Ill Patients. JoF 2022;8:308. [DOI: 10.3390/jof8030308] [Reference Citation Analysis]
68 Schuetz P. Personalized medicine of patients with respiratory infections through the measurement of specific blood biomarkers: fact or fiction? Expert Rev Respir Med 2017;11:605-7. [PMID: 28610545 DOI: 10.1080/17476348.2017.1338953] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
69 Liao M, Zheng J, Xu Y, Qiu Y, Xia C, Zhong Z, Liu L, Liu H, Liu R, Liang S. Development of magnetic particle-based chemiluminescence immunoassay for measurement of human procalcitonin in serum. J Immunol Methods 2021;488:112913. [PMID: 33189726 DOI: 10.1016/j.jim.2020.112913] [Reference Citation Analysis]
70 Grief SN, Loza JK. Guidelines for the Evaluation and Treatment of Pneumonia. Prim Care. 2018;45:485-503. [PMID: 30115336 DOI: 10.1016/j.pop.2018.04.001] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 4.8] [Reference Citation Analysis]
71 Chambliss AB. Embracing Procalcitonin for Antimicrobial Stewardship. J Appl Lab Med 2019;3:712-5. [PMID: 31639737 DOI: 10.1373/jalm.2018.026385] [Reference Citation Analysis]
72 Schuetz P, Wirz Y, Sager R, Christ-Crain M, Stolz D, Tamm M, Bouadma L, Luyt CE, Wolff M, Chastre J. Effect of procalcitonin-guided antibiotic treatment on mortality in acute respiratory infections: a patient level meta-analysis. Lancet Infect Dis. 2017; Epub ahead of print. [PMID: 29037960 DOI: 10.1016/s1473-3099(17)30592-3] [Cited by in Crossref: 199] [Cited by in F6Publishing: 70] [Article Influence: 39.8] [Reference Citation Analysis]
73 Huynh HH, Delatour V, Derbez-Morin M, Liu Q, Boeuf A, Vinh J. Candidate High-Resolution Mass Spectrometry-Based Reference Method for the Quantification of Procalcitonin in Human Serum Using a Characterized Recombinant Protein as a Primary Calibrator. Anal Chem 2022. [PMID: 35235744 DOI: 10.1021/acs.analchem.1c03061] [Reference Citation Analysis]
74 Bouldoires B, Gil H, Soumagne T, Humbert S, Meaux Ruault N, Magy Bertrand N. [A predictive bacterial infection score according to eosinophil level: An observational study]. Rev Med Interne 2018;39:10-6. [PMID: 29223347 DOI: 10.1016/j.revmed.2017.10.425] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
75 Saeed K, González Del Castillo J, Backous C, Drevet S, Ferrer R, Gavazzi G, Gluck E, Jensen JU, Kanizsai P, Ruiz-Rodríguez JC, Molnar G, Fazakas J, Umpleby H, Townsend J, Schuetz P. Hot topics on procalcitonin use in clinical practice, can it help antibiotic stewardship? Int J Antimicrob Agents 2019;54:686-96. [PMID: 31369813 DOI: 10.1016/j.ijantimicag.2019.07.016] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
76 Neeser O, Branche A, Mueller B, Schuetz P. How to: implement procalcitonin testing in my practice. Clinical Microbiology and Infection 2019;25:1226-30. [DOI: 10.1016/j.cmi.2018.12.028] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 5.3] [Reference Citation Analysis]
77 Schuetz P, Bretscher C, Bernasconi L, Mueller B. Overview of procalcitonin assays and procalcitonin-guided protocols for the management of patients with infections and sepsis. Expert Review of Molecular Diagnostics 2017;17:593-601. [DOI: 10.1080/14737159.2017.1324299] [Cited by in Crossref: 40] [Cited by in F6Publishing: 33] [Article Influence: 8.0] [Reference Citation Analysis]
78 Lee J, Bontekoe J, Trac B, Bansal V, Biller J, Hoppensteadt D, Maia P, Walborn A, Fareed J. Biomarker Profiling of Neurovascular Diseases in Patients with Stage 5 Chronic Kidney Disease. Clin Appl Thromb Hemost 2018;24:248S-54S. [PMID: 30348002 DOI: 10.1177/1076029618807565] [Reference Citation Analysis]
79 Lei H, Xu X, Wang C, Xue D, Wang C, Chen J. A host-based two-gene model for the identification of bacterial infection in general clinical settings. Int J Infect Dis 2021;105:662-7. [PMID: 33667695 DOI: 10.1016/j.ijid.2021.02.112] [Reference Citation Analysis]
80 Tujula B, Hämäläinen S, Kokki H, Pulkki K, Kokki M. Review of clinical practice guidelines on the use of procalcitonin in infections. Infectious Diseases 2020;52:227-34. [DOI: 10.1080/23744235.2019.1704860] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
81 Lei H, Wang C, Wang Y, Wang C. Single-cell RNA-Seq revealed profound immune alteration in the peripheral blood of patients with bacterial infection. Int J Infect Dis 2021;103:527-35. [PMID: 33278616 DOI: 10.1016/j.ijid.2020.11.205] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
82 Spellberg B. The Maturing Antibiotic Mantra: "Shorter Is Still Better". J Hosp Med 2018;13:361.362. [PMID: 29370317 DOI: 10.12788/jhm.2904] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
83 Meier MA, Branche A, Neeser OL, Wirz Y, Haubitz S, Bouadma L, Wolff M, Luyt CE, Chastre J, Tubach F, Christ-Crain M, Corti C, Jensen JS, Deliberato RO, Kristoffersen KB, Damas P, Nobre V, Oliveira CF, Shehabi Y, Stolz D, Tamm M, Mueller B, Schuetz P. Procalcitonin-guided Antibiotic Treatment in Patients With Positive Blood Cultures: A Patient-level Meta-analysis of Randomized Trials. Clin Infect Dis 2019;69:388-96. [PMID: 30358811 DOI: 10.1093/cid/ciy917] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 13.5] [Reference Citation Analysis]
84 Christensen I, Haug JB, Berild D, Bjørnholt JV, Jelsness-Jørgensen LP. Hospital physicians' experiences with procalcitonin - implications for antimicrobial stewardship; a qualitative study. BMC Infect Dis 2020;20:515. [PMID: 32677903 DOI: 10.1186/s12879-020-05246-6] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
85 Schneider JE, Romanowsky J, Schuetz P, Stojanovic I, Cheng HK, Liesenfeld O, Buturovic L, Sweeney TE. Cost Impact Model of a Novel Multi-mRNA Host Response Assay for Diagnosis and Risk Assessment of Acute Respiratory Tract Infections and Sepsis in the Emergency Department. J Health Econ Outcomes Res 2020;7:24-34. [PMID: 32685595 DOI: 10.36469/jheor.2020.12637] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
86 Blanchard F, Charbit J, Van der Meersch G, Popoff B, Picod A, Cohen R, Chemouni F, Gaudry S, Bihan H, Cohen Y. Early sepsis markers in patients admitted to intensive care unit with moderate-to-severe diabetic ketoacidosis. Ann Intensive Care 2020;10:58. [PMID: 32430795 DOI: 10.1186/s13613-020-00676-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
87 Ni W, Bao J, Yang D, Xi W, Wang K, Xu Y, Zhang R, Gao Z. Potential of serum procalcitonin in predicting bacterial exacerbation and guiding antibiotic administration in severe COPD exacerbations: a systematic review and meta-analysis. Infect Dis (Lond) 2019;51:639-50. [PMID: 31355690 DOI: 10.1080/23744235.2019.1644456] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
88 Heo W, Park HD. Analytical and clinical performance of the Advansure i3 procalcitonin assay. Scand J Clin Lab Invest 2021;81:546-51. [PMID: 34601986 DOI: 10.1080/00365513.2021.1969592] [Reference Citation Analysis]
89 Cabral L, Afreixo V, Meireles R, Vaz M, Chaves C, Caetano M, Almeida L, Paiva JA. Checking procalcitonin suitability for prognosis and antimicrobial therapy monitoring in burn patients. Burns Trauma 2018;6:10. [PMID: 29610766 DOI: 10.1186/s41038-018-0112-5] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
90 Borges-gonzález J, Kousseff CJ, Nielsen CB. Organic semiconductors for biological sensing. J Mater Chem C 2019;7:1111-30. [DOI: 10.1039/c8tc05900d] [Cited by in Crossref: 45] [Article Influence: 15.0] [Reference Citation Analysis]
91 Wirz Y, Branche A, Wolff M, Welte T, Nobre V, Reinhart K, Falsey AR, Damas P, Beishuizen A, Deliberato RO, Shehabi Y, Jensen JS, Mueller B, Schuetz P. Management of Respiratory Infections with Use of Procalcitonin: Moving toward More Personalized Antibiotic Treatment Decisions. ACS Infect Dis 2017;3:875-9. [PMID: 29120606 DOI: 10.1021/acsinfecdis.7b00199] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
92 Qiu Q, Nian YJ, Tang L, Guo Y, Wen LZ, Wang B, Chen DF, Liu KJ. Artificial neural networks accurately predict intra-abdominal infection in moderately severe and severe acute pancreatitis. J Dig Dis 2019;20:486-94. [PMID: 31328389 DOI: 10.1111/1751-2980.12796] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
93 Huynh HH, Bœuf A, Vinh J, Delatour V; IFCC Working Group on Standardization of Procalcitonin assays (WG-PCT). Evaluation of the necessity and the feasibility of the standardization of procalcitonin measurements: Activities of IFCC WG-PCT with involvement of all stakeholders. Clin Chim Acta 2021;515:111-21. [PMID: 33450213 DOI: 10.1016/j.cca.2021.01.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
94 Kiss S, Gede N, Hegyi P, Németh D, Földi M, Dembrovszky F, Nagy B, Juhász MF, Ocskay K, Zádori N, Molnár Z, Párniczky A, Hegyi PJ, Szakács Z, Pár G, Erőss B, Alizadeh H. Early changes in laboratory parameters are predictors of mortality and ICU admission in patients with COVID-19: a systematic review and meta-analysis. Med Microbiol Immunol 2021;210:33-47. [PMID: 33219397 DOI: 10.1007/s00430-020-00696-w] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
95 Wojtalewicz N, Schellenberg I, Hunfeld KP. Evaluation of INSTAND e.V.'s external quality assessment for C-reactive protein and procalcitonin. PLoS One 2019;14:e0221426. [PMID: 31419260 DOI: 10.1371/journal.pone.0221426] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
96 Adembri C, Novelli A, Nobili S. Some Suggestions from PK/PD Principles to Contain Resistance in the Clinical Setting-Focus on ICU Patients and Gram-Negative Strains. Antibiotics (Basel) 2020;9:E676. [PMID: 33036190 DOI: 10.3390/antibiotics9100676] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
97 Sammel AM, Xue M, Karsten E, Little CB, Smith S, Nguyen K, Laurent R. Limited utility of novel serological biomarkers in patients newly suspected of having giant cell arteritis. Int J Rheum Dis 2021;24:781-8. [PMID: 33847438 DOI: 10.1111/1756-185X.14111] [Reference Citation Analysis]
98 Eidizadeh A, Wiederhold M, Schnelle M, Binder L. Comparison of a novel automated DiaSys procalcitonin immunoassay with four different BRAHMS-partnered immunoassays. Practical Laboratory Medicine 2022;30:e00274. [DOI: 10.1016/j.plabm.2022.e00274] [Reference Citation Analysis]
99 Troia R, Giunti M, Goggs R. Plasma procalcitonin concentrations predict organ dysfunction and outcome in dogs with sepsis. BMC Vet Res 2018;14:111. [PMID: 29580242 DOI: 10.1186/s12917-018-1427-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
100 Sun Y, Jiang L, Shao X. Predictive value of procalcitonin for diagnosis of infections in patients with chronic kidney disease: a comparison with traditional inflammatory markers C-reactive protein, white blood cell count, and neutrophil percentage. Int Urol Nephrol 2017;49:2205-16. [DOI: 10.1007/s11255-017-1710-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
101 Liu C, Peng Z, Cui L, Wang T, Wu Y. Influence of hemolysis on serum procalcitonin measured by electrochemiluminescence in an emergency room. Anal Methods 2021;13:3410-3. [PMID: 34254068 DOI: 10.1039/d1ay00442e] [Reference Citation Analysis]
102 Mohan R, Srirangarajan, Rao RJ, Prabhu S, Rudresh V. Utility of procalcitonin as an early diagnostic marker of bacteremia in individuals with periodontitis Stage II and III. J Periodontol 2021;92:968-74. [PMID: 33151545 DOI: 10.1002/JPER.20-0513] [Reference Citation Analysis]
103 Iankova I, Thompson-leduc P, Kirson NY, Rice B, Hey J, Krause A, Schonfeld SA, Debrase CR, Bozzette S, Schuetz P. Efficacy and Safety of Procalcitonin Guidance in Patients With Suspected or Confirmed Sepsis: A Systematic Review and Meta-Analysis*. Critical Care Medicine 2018;46:691-8. [DOI: 10.1097/ccm.0000000000002928] [Cited by in Crossref: 44] [Cited by in F6Publishing: 22] [Article Influence: 11.0] [Reference Citation Analysis]
104 Gutiérrez-Pizarraya A, León-García MDC, De Juan-Idígoras R, Garnacho-Montero J. Clinical impact of procalcitonin-based algorithms for duration of antibiotic treatment in critically ill adult patients with sepsis: a meta-analysis of randomized clinical trials. Expert Rev Anti Infect Ther 2021;:1-10. [PMID: 34027785 DOI: 10.1080/14787210.2021.1932462] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
105 Wolfisberg S, Gregoriano C, Schuetz P. Procalcitonin for individualizing antibiotic treatment: an update with a focus on COVID-19. Crit Rev Clin Lab Sci 2021;:1-12. [PMID: 34517744 DOI: 10.1080/10408363.2021.1975637] [Reference Citation Analysis]
106 Roy A, Powers HR, Craver EC, Nazareno MD, Yarrarapu SNS, Sanghavi DK. Antibiotic stewardship: Early discontinuation of antibiotics based on procalcitonin level in COVID-19 pneumonia. J Clin Pharm Ther 2021. [PMID: 34766357 DOI: 10.1111/jcpt.13554] [Reference Citation Analysis]
107 Tursi A, Scarpignato C, Strate LL, Lanas A, Kruis W, Lahat A, Danese S. Colonic diverticular disease. Nat Rev Dis Primers 2020;6:20. [PMID: 32218442 DOI: 10.1038/s41572-020-0153-5] [Cited by in Crossref: 24] [Cited by in F6Publishing: 13] [Article Influence: 12.0] [Reference Citation Analysis]
108 Yao J, Jiang L, Xue D, Sun Y. Predictive value of procalcitonin in chronic allograft dysfunction in kidney transplant recipients. Exp Ther Med 2019;18:4603-8. [PMID: 31777558 DOI: 10.3892/etm.2019.8113] [Reference Citation Analysis]
109 Oppert M. [Diagnosis of sepsis and guidance of antibiotic therapy]. Med Klin Intensivmed Notfmed 2019;114:286-9. [PMID: 30944943 DOI: 10.1007/s00063-019-0570-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.7] [Reference Citation Analysis]
110 Huynh HH, Bœuf A, Derbez-Morin M, Dupuy AM, Lalere B, Delatour V, Vinh J. Development of an antibody-free ID-LC MS method for the quantification of procalcitonin in human serum at sub-microgram per liter level using a peptide-based calibration. Anal Bioanal Chem 2021;413:4707-25. [PMID: 33987701 DOI: 10.1007/s00216-021-03361-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
111 Cortegiani A, Misseri G, Ippolito M, Bassetti M, Giarratano A, Martin-Loeches I, Einav S. Procalcitonin levels in candidemia versus bacteremia: a systematic review. Crit Care 2019;23:190. [PMID: 31138262 DOI: 10.1186/s13054-019-2481-y] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 5.7] [Reference Citation Analysis]
112 Yang Y, Hao Q, Flaherty JH, Cao L, Zhou J, Su L, Shen Y, Dong B. Comparison of procalcitonin, a potentially new inflammatory biomarker of frailty, to interleukin-6 and C-reactive protein among older Chinese hospitalized patients. Aging Clin Exp Res 2018;30:1459-64. [PMID: 29777476 DOI: 10.1007/s40520-018-0964-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
113 De Ruffi S, Gornet M, Ramont L, Leroux P, Giordano Orsini G, Losset X, Kanagaratnam L, Gennai S. Analysis of 1635 procalcitonin prescriptions in the emergency department of a university hospital: A gap between evidence-based medicine and the real world? Int J Clin Pract 2021;75:e14001. [PMID: 33998759 DOI: 10.1111/ijcp.14001] [Reference Citation Analysis]
114 Polilli E, Sozio F, Frattari A, Persichitti L, Sensi M, Posata R, Di Gregorio M, Sciacca A, Flacco ME, Manzoli L, Di Iorio G, Parruti G. Comparison of Monocyte Distribution Width (MDW) and Procalcitonin for early recognition of sepsis. PLoS One 2020;15:e0227300. [PMID: 31923207 DOI: 10.1371/journal.pone.0227300] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
115 Covington EW, Roberts MZ, Dong J. Procalcitonin Monitoring as a Guide for Antimicrobial Therapy: A Review of Current Literature. Pharmacotherapy 2018;38:569-81. [PMID: 29604109 DOI: 10.1002/phar.2112] [Cited by in Crossref: 21] [Cited by in F6Publishing: 12] [Article Influence: 5.3] [Reference Citation Analysis]
116 Huynh HH, Bœuf A, Pfannkuche J, Schuetz P, Thelen M, Nordin G, van der Hagen E, Kaiser P, Kesseler D, Badrick T, Poggi B, Tiikkainen U, Davies GJ, Kessler A, Plebani M, Vinh J, Delatour V. Harmonization status of procalcitonin measurements: what do comparison studies and EQA schemes tell us? Clin Chem Lab Med 2021;59:1610-22. [PMID: 34147043 DOI: 10.1515/cclm-2021-0566] [Reference Citation Analysis]
117 Loo LW, Liew YX, Chlebicki P, Kwa AL. Discontinuation of Antibiotics in Patients with Neurological Conditions - A Study on the Impact of an Antimicrobial Stewardship Program (ASP) in a Tertiary Institution. Int J Antimicrob Agents 2020;56:106038. [PMID: 32479888 DOI: 10.1016/j.ijantimicag.2020.106038] [Reference Citation Analysis]
118 Lai L, Lai Y, Wang H, Peng L, Zhou N, Tian Y, Jiang Y, Gong G. Diagnostic Accuracy of Procalcitonin Compared to C-Reactive Protein and Interleukin 6 in Recognizing Gram-Negative Bloodstream Infection: A Meta-Analytic Study. Dis Markers 2020;2020:4873074. [PMID: 32076461 DOI: 10.1155/2020/4873074] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
119 Su'a B, Tutone S, Macfater W, Barazanchi A, Xia W, Zeng I, Hill AG. Diagnostic accuracy of procalcitonin for the early diagnosis of anastomotic leakage after colorectal surgery: a meta‐analysis. ANZ Journal of Surgery 2020;90:675-80. [DOI: 10.1111/ans.15291] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
120 Eidizadeh A, Asif AR, von Ahsen N, Binder L, Schnelle M. Differences in procalcitonin measurements between three BRAHMS-partnered immunoassays (Liaison, Elecsys and Architect). Clinical Chemistry and Laboratory Medicine (CCLM) 2019;57:e207-10. [DOI: 10.1515/cclm-2018-0916] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
121 Nora D, Salluh J, Martin-Loeches I, Póvoa P. Biomarker-guided antibiotic therapy-strengths and limitations. Ann Transl Med 2017;5:208. [PMID: 28603723 DOI: 10.21037/atm.2017.04.04] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 5.6] [Reference Citation Analysis]
122 Vassallo C, Borg AA, Farrugia D, Mercieca C. The Epidemiology and Outcomes of Septic Arthritis in the Maltese Islands: A Hospital-Based Retrospective Cohort Study. Mediterr J Rheumatol 2020;31:195-205. [PMID: 32676557 DOI: 10.31138/mjr.31.2.195] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
123 Cole JL. Implementation of the Procalcitonin Assay in a Rural Hospital. Hosp Pharm 2018;53:395-402. [PMID: 30559527 DOI: 10.1177/0018578718762128] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
124 Tang Y, Li Y, Sun J, Pan H, Yao F, Jiao X. Selection of an Optimal Combination Panel to Better Triage COVID-19 Hospitalized Patients. J Inflamm Res 2020;13:773-87. [PMID: 33149652 DOI: 10.2147/JIR.S273193] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
125 Wang D, Caddell B, Nolte FS, Babic N. Comparison of the Abbott Architect BRAHMS and the Biomérieux Vidas BRAHMS Procalcitonin Assays. The Journal of Applied Laboratory Medicine 2019;3:580-6. [DOI: 10.1373/jalm.2018.027268] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
126 Carcamo Yañez VA, Göpfert JC, Otto M, Tumani H, Peter A, Joos TO. Development and Validation of an Ultrasensitive Procalcitonin Sandwich Immunoassay. High Throughput 2017;6:E18. [PMID: 29479055 DOI: 10.3390/ht6040018] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
127 Weiss ZF, Cunha CB, Chambers AB, Carr AV, Rochat C, Raglow-Defranco M, Parente DM, Angus A, Mermel LA, Sivaprasad L, Chapin K. Opportunities Revealed for Antimicrobial Stewardship and Clinical Practice with Implementation of a Rapid Respiratory Multiplex Assay. J Clin Microbiol 2019;57:e00861-19. [PMID: 31413077 DOI: 10.1128/JCM.00861-19] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 3.7] [Reference Citation Analysis]